NCT07254208
A Long-term Observational Study in Participants Who Have Received PBGENE-HBV
Enrolling by Invitation
Not specifiedAges 19–80ObservationalPrecision BioSciences, Inc.
~45 participants
Updated 2026-04-22 on ClinicalTrials.gov
What's tested:PBGENE-HBV
At a glance
Recruiting sites
0 of 4 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Safety to assess frequency, severity, and outcome of delayed adverse events
Measured over 15 years
Conditions
Where it's being run
4 sites across 4 statesMassachusetts1
Hong Kong1
Moldova1
New Zealand1
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Exclusion
N/A
What this trial measures
- Safety to assess frequency, severity, and outcome of delayed adverse events15 years
Delayed adverse events